BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4773075)

  • 1. Determination of the acetylator phenotype from the ratio of the urinary excretion of acetylisoniazid to acid-labile isoniazid: a study in Finnish Lapland.
    Ellard GA; Gammon PT; Tiitinen H
    Tubercle; 1973 Sep; 54(3):201-10. PubMed ID: 4773075
    [No Abstract]   [Full Text] [Related]  

  • 2. The determination of isoniazid and its metabolites acetylisoniazid, monoacetylhydrazine, diacetylhydrazine, isonicotinic acid and isonicotinylglycine in serum and urine.
    Ellard GA; Gammon PT; Wallace SM
    Biochem J; 1972 Feb; 126(3):449-58. PubMed ID: 5075259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the acetylator phenotype using matrix isoniazid.
    Ellard GA; Gammon PT; Titinen H
    Tubercle; 1975 Sep; 56(3):203-9. PubMed ID: 1216339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of isoniazid and metabolites in biological fluids.
    Boxenbaum HG; Riegelman S
    J Pharm Sci; 1974 Aug; 63(8):1191-7. PubMed ID: 4851320
    [No Abstract]   [Full Text] [Related]  

  • 5. Simple method for determining isoniazid acetylator phenotype.
    Russell DW
    Br Med J; 1970 Aug; 3(5718):324-5. PubMed ID: 5451955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoniazid and ethionamide serum levels and inactivation in Finnish subjects.
    Tiitinen H
    Scand J Respir Dis; 1969; 50(2):110-24. PubMed ID: 5195839
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluorometric determination of isoniazid and its metabolites in urine by high-performance liquid chromatography using in-line derivatization.
    Kohno H; Kubo H; Furukawa K; Yoshino N; Nishikawa T
    Ther Drug Monit; 1991 Sep; 13(5):428-32. PubMed ID: 1957336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of subjects as slow or rapid inactivators of isoniazid, based on the ratio of the urinary excretion of acetylisoniazid to isoniazid.
    Venkataraman P; Menon NK; Nair NG; Radhakrishna S; Ross C; Tripathy SP
    Indian J Med Res; 1972 May; 60(5):685-93. PubMed ID: 4663236
    [No Abstract]   [Full Text] [Related]  

  • 9. A radioimmunoassay for isoniazid.
    Schwenk R; Kelly K; Tse KS; Sehon AH
    Clin Chem; 1975 Jul; 21(8):1059-62. PubMed ID: 124237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoniazid inactivation in Finns and Lapps as demonstrated by various methods.
    Tittinen H; Mattila MJ; Eriksson AW
    Am Rev Respir Dis; 1973 Aug; 108(2):375-8. PubMed ID: 4720700
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of the acetylator phenotype in Moroccan tuberculosis patients using isoniazid as metabolic probe.
    Aït Moussa L; Khassouani CE; Hüe B; Jana M; Bégaud B; Soulaymani R
    Int J Clin Pharmacol Ther; 2002 Dec; 40(12):548-53. PubMed ID: 12503812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of isoniazid by Canadian Eskimos and Indians.
    Jeanes CW; Schaefer O; Eidus L
    Can Med Assoc J; 1972 Feb; 106(4):331-5. PubMed ID: 5061127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of acetylator phenotype based on the ratio of acetylisoniazid to isoniazid in urine following an oral dose of ordinary isoniazid.
    Raghupati Sarma G; Kannapirin G; Narayana AS; Radhakrishna S; Tripathy SP
    Indian J Med Res; 1976 Jan; 64(1):1-8. PubMed ID: 1270091
    [No Abstract]   [Full Text] [Related]  

  • 14. A simple method for determining acetylator phenotype using isoniazid.
    Hutchings A; Routledge PA
    Br J Clin Pharmacol; 1986 Sep; 22(3):343-5. PubMed ID: 3768246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of a method of analysis using high performance liquid chromatography of isoniazid and acetylisoniazid to determine the phenotype of acetylation].
    Miscoria G; Leneveu A; Walle C; Roux A
    Ann Biol Clin (Paris); 1988; 46(9):734-40. PubMed ID: 3223632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of rifampin, phenobarbital pretreatment, and acetylator phenotype on acetylisoniazid metabolism in the rabbit.
    Thomas BH; Zeitz W; Whitehouse LW
    Can J Physiol Pharmacol; 1987 Mar; 65(3):419-23. PubMed ID: 3580961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single sample saliva test to determine acetylator phenotype.
    Hutchings AD; Routledge PA
    Br J Clin Pharmacol; 1996 Nov; 42(5):635-7. PubMed ID: 8951197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylator phenotyping of tuberculosis patients using matrix isoniazid or sulphadimidine and its prognostic significance for treatment with several intermittent isoniazid-containing regimens.
    Ellard GA; Gammon PT
    Br J Clin Pharmacol; 1977 Feb; 4(1):5-14. PubMed ID: 843424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of the potential use of isoniazid, acetylisoniazid and isonicotinic acid for monitoring the self-administration of drugs.
    Ellard GA; Jenner PJ; Downs PA
    Br J Clin Pharmacol; 1980 Oct; 10(4):369-81. PubMed ID: 7448108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylation phenotyping of isoniazid using a simple and accurate high-performance liquid chromatography.
    el-Sayed YM; Islam SI
    J Clin Pharm Ther; 1989 Jun; 14(3):197-205. PubMed ID: 2760118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.